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Abstract
Introduction:  The current study aimed to assess the reliability, validity and psychometric
properties of the Greek translation of the Zung Depression Rating Scale (ZDRS).
Methods: The study sample included 40 depressed patients 29.65 ± 9.38 years old and 120 normal
comparison subjects 27.23 ± 10.62 years old. In 20 of them (12 patients and 8 comparison subjects)
the instrument was re-applied 1–2 days later. Translation and Back Translation was made. Clinical
Diagnosis was reached by consensus of two examiners with the use of the SCAN v.2.0 and the
IPDE. Statistical Analysis included ANOVA, the Pearson Product Moment Correlation Coefficient,
Principal Components Analysis and Discriminant Function Analysis and the calculation of
Cronbach's alpha (α )
Results: Both Sensitivity and specificity exceed 90.00 at 44/45, Chronbach's alpha for the total
scale was equal to 0.09, suggesting that the scale covers a broad spectrum of symptoms. Factor
analysis revealed five factors (anxiety-depression, thought content, gastrenterological symptoms,
irritability and social-interpersonal functioning). The test-retest reliability was satisfactory
(Pearson's R between 0.92).
Conclusion: The ZDRS-Greek translation is both reliable and valid and is suitable for clinical and
research use with satisfactory properties. Its properties are similar to those reported in the
international literature, although the literature is limited. However one should always have in mind
the limitations inherent in the use of self-report scales.
Background
The Zung Depression Rating Scale (ZDRS) [1] is a self-re-
porting instrument and was originally developed in order
to assess depression symptoms without the bias of an ad-
ministrator affecting the results. The items in the ZDRS
scale may also help patients begin to discuss previously
nebulous symptoms, especially those patients who
present with physical symptoms of depression such as
headache or insomnia.
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The ZDRS is a well-known and world-widely used self-rat-
ing scale for the measurement of depression. Along with
the Beck Depression Inventory [2] and the CES-D[3,4]
these are the most popular self-administered instruments
for the assessment of depression. They are supposed to be
used as screening tools rather and not substitutes for an
in-depth interview [5]. They can also be an efficient tool
for screening patients for depression [6] and have been
used successfully for many years in the primary care set-
ting. Higher scores on this scale are indicative of more se-
vere depression [7]
ZDRS consists of 20 items that cover affective, psycholog-
ical, and somatic symptoms. The patient specifies the fre-
quency with which the symptom is experienced (that is: a
little = 1, some = 2, a good part of the time = 3, or most of
the time = 4) [8].
Except from the use of the raw ZDRS score, another way to
rate is the SDS index, which is obtained by dividing the
ZDRS raw score with 80, which is the maximum score.
Minimum score is 20. It is expected that most people with
depression score above 50 (SDS index 0.62). A subject
with ZDRS score below 50 is considered normal, with a
score of 50–59 (SDS 0.62–0.74) is considered to suffer
from mild depression, with score 60–69 (SDS 0.75–0.86)
depression is considered moderate to marked, while with
a score of 70 or above depression is considered to be se-
vere.
The aim of the current study was to assess the reliability,
validity and psychometric properties of the Greek transla-
tion of the Zung Depression Rating Scale
Material and methods
Material
Forty patients (25 males and 15 females) aged 29.65 ±
9.38 years (range 18–55) suffering from Major Depressive
disorder according to DSM-IV [9] and depression accord-
ing to ICD-10 criteria [10], and 120 normal comparison
subjects (71 males and 49 females aged 27.23 ± 10.62
years (range 18–51) entered the study. In 20 of them (12
patients and 8 normal comparison subjects) the instru-
ment was re-applied 1–2 days later.
Patients and normal comparison subjects were free of any
medication for at least two weeks and were physically
healthy with normal clinical and laboratory findings
(Electroencephalogram, blood and biochemical testing,
thyroid function, test for pregnancy, 12 and folic acid).
Patients came from the inpatient and outpatient unit of
the 3rd Department of Psychiatry, Aristotle University of
Thessaloniki, General Hospital AHEPA, Thessaloniki,
Greece. They were consecutive cases and were chosen be-
cause they fulfilled the above criteria.
The normal comparison group was composed of mem-
bers of the hospital staff and relatives of patients. A clini-
cal interview confirmed that they did not suffer from any
mental disorder and their prior history was free from
mental and thyroid disorder.
All patients and normal comparison subjects provided
written informed consent before participating in the
study.
Note: the study sample was identical with that used for the
CES-D standardization study[4]
Method
Translation and back translation was made by two of the
authors, one of whom did not knew the original English
text. The final translation was fixed by consensus.
Clinical diagnosis was reached by consensus of two ex-
aminers. The Schedules for Clinical Assessment in Neu-
ropsychiatry (SCAN) version 2.0 [11,12] and the
International Personality Disorders Examination (IPDE)
[13–15] were used. Both were applied by one of the au-
thors (KNF) who has official training in a World Health
Organization Training and Reference Centre. The IPDE
did not contribute to the clinical diagnosis of depression,
but was used in the frame of a global and comprehensive
assessment of the patients. The second examiner per-
formed an unstructured interview.
Procedure
The identification of potential cases and normal compar-
ison subjects was done first and subjects were referred for
detailed evaluation. The use of structured interviews and
the final consensus decision of the two examiners deter-
mined which subjects would be included in the study.
Testing with the ZDRS followed.
Statistical analysis
Analysis of Variance (ANOVA) [16] was used to search for
differences between groups. The Pearson Product Mo-
ment Correlation Coefficient R was calculated to assess
the test-retest reliability. Principal Components Analysis
(Varimax Normalized Rotation) was performed, and fac-
tor coefficients and scores were calculated. Finally, Discri-
minant Function Analysis was performed as well.
Item Analysis [17] was performed, and the value of Cron-
bach's alpha (α ) for ZDRS and its factor subscales was cal-
culated. Receiver Operator Characteristic Curves (ROC
curves) and histogram of frequencies were created as well.BMC Psychiatry 2001, 1 http://www.biomedcentral.com/1471-244X/1/6
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Results
The calculation of sensitivity (Sn) and specificity (Sp) at
various cut-off levels showed that both variables exceed
90.00 at 44/45 (SDS 0.55/0.56), with 111 normal com-
parison subjects and 36 patients correctly classified. Nine
9 normal comparison subjects and 4 patients were classi-
fied into a wrong diagnostic group (table 1). Receiver Op-
eration Curve Analysis (figure 1) confirmed these results.
Chronbach's alpha for the total scale was equal to 0.09,
and this is a very low value, suggesting that the scale cov-
ers a broad spectrum of symptoms and represents a global
assessment of depression.
The histogram of ZDRS scores in normal comparison sub-
jects reveals that they do not follow the normal distribu-
tion in this population, but manifest a skewness towards
lower values (figure 2).
The factor analysis of cases (varimax normalized rotation)
revealed five factors (table 2). The first one explained 15%
of total variance, included items No 1, 2, 4, 9 and 10 and
largely reflects a factor of anxiety-depression. The second
one explained 16% of total variance, included items No
11, 12, 14, 16, 17, 18 and 20 and largely reflects a cogni-
tive (thought content) factor. The third factor explained
11% of total variance, included items No 5, 7 and 8 and
reflects gastrenterological symptoms. The fourth ex-
plained 10% of total variance, included items No 11, 12
and 15 and represents an aspect of symptomatology sim-
ilar with factor 2, with the addition of irritability. The last
factor explained 13% of total variance, included items No
3, 6, 10 and 19 and reflects social and interpersonal func-
tioning. Factor loadings and coefficients are shown in ta-
ble 2. All five factors explained 64% of total ZDRS
variance.
Chronbach's alpha for the individual factors (subscales
that include the items that load in each one) was fair, with
values from 0.23 to 0.45. Only factor 2 had high internal
consistency with alpha equal to 0.86.
Depressed patients did not differ from normal compari-
son subjects in age. On the contrary they differed in every
ZDRS individual item score and total score (p < 0.001 –
table 3). It is very interesting that the two groups differed
in the scores of factors 1, 3 and 5 (p < 0.001), that is in the
essence of anxiety, depression, gastrenterological symp-
toms, and social and interpersonal functioning, but not in
the score of factors 2 and 4, that is thought content and ir-
ritability.
The test-retest reliability proved to be satisfactory. Individ-
ual items had good Pearson correlation coefficients with
lower for item No 6 (R = 0.51) and higher for item No 7
(R = 0.89). The coefficient for the total ZDRS score was ex-
cellent and equal to 0.92.
Discriminant function analysis results are shown in table
4. Two separate analyses were performed, with the for-
ward stepwise method, one with individual ZDRS items
and a second with factor scores. The first one performed
excellently while the second one was fair. The results of
the first one suggest that when the D-C equation, that is:
2.65*(itl) - 0.45*(it2) + 2.03*(it3) + 1.14*(it4) -
0.97*(it6) + 1.56*(it7) + 0.82*(it8) + 1.18*(it9) +
1.13*(it10) + 1.02*(it11) - 2.37*(it12) - 1.46*(it15) +
0.91*(itl6) + 0.97*(itl7) takes values above 15.52, then
the subject is a depressed patient. This method correctly
classified all normal comparison subjects and 90% of pa-
tients.
Figure 1
ROC analysis Curve-the score level 44/45 has the largest dis-
tance from the dichotomous
Table 1: Sensitivity and Specificity of ZDRS at various cut-off lev-
els. The optimum is at level 44/45
ZUNG
level tn fp fn tp Sn Sp
41/42 103 17 2 38 95.00 85.83
42/43 105 15 3 37 92.50 87.50
43/44 107 13 3 37 92.50 89.17
44/45 111 9 4 36 90.00 92.50
45/46 112 8 7 33 82.50 93.33
46/47 112 8 9 31 77.50 93.33
47/48 114 6 10 30 75.00 95.00
48/49 114 6 10 30 75.00 95.00
49/50 114 6 10 30 75.00 95.00
50/51 114 6 11 29 72.50 95.00BMC Psychiatry 2001, 1 http://www.biomedcentral.com/1471-244X/1/6
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Discussion
Self-administered scales heavily depend on the co-opera-
tion and reading ability of the patient. On the other hand
they save time for the clinician. More, translations are dif-
ficult to access because of publication in various languag-
es or national journals [18–21].
The current study reports observations on the reliability,
the validity and psychometric properties of the Greek
translation of the Zung Depression Rating Scale. The re-
sults suggest that this translation is well suited for use in
the Greek population with high sensitivity and specificity
at the cut-off level 44/45 and high test-retest reliability.
The reliability and validity of the Zung Depression Rating
Scale has been examined in only a limited number of
studies and not many translations of this scale have been
published. In the original study [1] this scale was found be
able to differentiate between depressed patients and nor-
mal comparison subjects. Later studies showed the rela-
tionship of the scale with the clinician's assessment of
severity, the Beck Depression Inventory, the D dimension
of the MMPI and an unstable relationship with the Ham-
ilton Depression Rating Scale [22–26].
The highest published cut-point for the ZDRS was 60/61
[27] and with an unusually low sensitivity for detecting
major depression. Other studies generally accept the level
49/50 and report 97% sensitivity and 63% specificity.
In another study, 69 randomly selected medical outpa-
tients were clinically evaluated for depressive illness.
ZDRS identified 30% of those depressed while missing
those whose depression was presented under the guise of
somatic illness [28].
While there are data supporting the content and construct
validity of the ZDRS, the evidence regarding its reliability
Table 2: Factor loadings and coefficients after Factor Analysis (Varimax normalized rotation) of normal comparison subjects and 
patients data
Factor Loadings Factor Coefficients
Factor Factor Factor Factor Factor Factor Factor Factor Factor Factor
I t e m  N o 1 2 34512345
1 0.53 -0.30 -0.38 -0.23 0.45 0.12 0.07 -0.08 0.01 0.12
2 -0.59 0.44 0.08 0.03 0.25 -0.32 0.23 -0.06 -0.11 0.38
3 0.27 -0.17 -0.29 -0.07 0.74 -0.03 0.15 -0.06 0.09 0.41
4 0.75 -0.16 -0.07 -0.05 0.14 0.40 0.05 0.10 0.12 -0.07
5 -0.12 0.39 0.66 0.05 -0.12 0.10 0.10 0.38 -0.09 0.09
6 0.03 0.19 0.11 0.40 -0.66 0.24 -0.08 -0.06 0.24 -0.40
7 0.25 -0.24 -0.70 0.29 0.20 0.05 0.01 -0.44 0.37 -0.01
8 0.03 0.05 -0.70 -0.32 0.05 -0.13 0.17 -0.46 -0.16 -0.05
9 0.73 0.01 -0.03 -0.23 0.30 0.36 0.20 0.13 -0.03 0.09
10 0.49 -0.15 -0.26 -0.20 0.46 0.14 0.13 -0.03 0.00 0.18
11 -0.28 0.43 0.33 0.47 -0.12 0.03 0.11 0.07 0.22 0.12
12 -0.26 0.43 0.29 0.43 -0.25 0.06 0.09 0.04 0.20 0.01
13 0.63 -0.13 -0.38 -0.32 0.15 0.24 0.12 -0.12 -0.07 -0.08
14 -0.32 0.51 0.21 0.34 -0.26 0.01 0.15 -0.03 0.12 0.02
15 0.26 -0.14 0.01 -0.72 0.09 0.00 0.03 0.15 -0.47 -0.04
16 -0.21 0.60 0.13 0.29 -0.06 0.04 0.28 -0.06 0.12 0.15
17 0.05 0.79 0.10 -0.02 -0.17 0.18 0.44 -0.05 -0.09 0.06
18 -0.29 0.64 0.21 0.08 -0.41 0.02 0.22 -0.03 -0.09 -0.08
19 0.24 -0.46 0.14 0.31 0.60 0.06 -0.15 0.23 0.33 0.32
20 -0.24 0.51 0.12 0.32 -0.35 0.06 0.15 -0.09 0.13 -0.07
Expl. Var 3.08 3.14 2.22 1.93 2.50
Prp. Totl 15% 16% 11% 10% 13%
Total Var 0.64%
ExplBMC Psychiatry 2001, 1 http://www.biomedcentral.com/1471-244X/1/6
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Table 3: Greek translation of the ZDRS and comparison between normal comparison subjects and patients
normal
depressed comparison
subjects
SDS item No description Mean s.d. Mean s.d. P
Age 29.65 9.38 27.23 10.62 0.233
1 I feel down-hearted and blue 3.08 0.87 1.43 0.59 0.000
Aισθ άν oµαι  κακ óκεφ oς  και  έχω  τις  µα ύρες  µoυ
2 Morning is when I feel the best 1.95 1.05 2.76 0.99 0.000
To πρω ί αισθ άν oµαι  καλ ύτερα
3 I have crying spells or feel like it 2.51 0.85 1.28 0.50 0.000
Kλα ίω  ή µoύρχεται  να  κλ άψω
4 I have trouble sleeping at night 2.44 1.14 1.32 0.70 0.000
'Eχω  πρ oβλ ήµατα  µε  τ oν  ύπν o µoυ  τη  ν ύχτα
5 I eat as much as I used to 2.08 0.96 3.07 0.93 0.000
Tρ ώω  óσ o έτρωγα  συν ήθως
6 I enjoy looking at, talking to and being with attractive women/men 2.15 1.16 3.33 0.92 0.000
Moυ  αρ έσει  να  κ oιτ άω , να  µιλ άω  και  να  βρ ίσκ oµαι  µε  ελκυστικ ές
γυνα ίκες /άν óρες
7 I notice that I am loosing weight 2.28 1.07 1.27 0.56 0.000
Παρατηρ ώ óτι  χ άνω  β άρ oς
8 I have trouble with constipation 1.92 1.20 1.22 0.57 0.000
'Eχω  πρ óβληµα  δυσκ oιλι óτητας
9 My heart beats faster than usual 2.28 1.05 1.30 0.51 0.000
H καρδι ά µoυ  χτυπ ά γρηγ oρ óτερα  απ ´ τ o συνηθισµ έν o
10 I get tired for no reason 2.90 1.02 1.47 0.73 0.000
Koυρ άζ oµαι  χωρ ίς  να  υπ άρχει  λ óγ oς
11 My mind is as clear as I used to be 2.21 0.95 3.20 0.96 0.000
To µυαλ ó µoυ  ε ίναι  τ óσ o καθαρ ó óσ o ήταν  π άντα .
12 I find it easy to do the things I used to 1.56 0.64 3.15 0.97 0.000
Moυ  ε ίναι  ε ύκ oλ o να  κ άνω  τα  πρ άγµατα  π oυ  π άντα  έκανα
13 I am restless and can't keep still 2.77 0.90 1.61 0.79 0.000
Eιµαιαν  ήσυχ oς  και  δε  µπ oρ ώ να  καθ ήσω  ακ ίνητ oς .
14 I feel hopeful about the future 1.87 0.92 3.18 1.00 0.000
Aισθ άν oµαι  αισι óδ oξα  για  τ o µέλλ oν
15 I am more irritable than usual 7.38 0.96 1.87 0.94 0.003
Eίµαιπερι  σσδτερ o ευερ έθιστ oζ  απ ó τ o συνηθισµ έν o
16 I find it easy to make decisions 2.08 0.93 2.75 0.96 0.000
To βρ ίσκω  ε ύκ oλ o να  πα ίρνω  απ oφ άσειζ
17 I feel that I am useful and needed 2.51 1.14 3.00 0.93 0.008
Aισθ άν oµαι  óτι  ε ίµαι  Χρ ήσιµ oζ  και  µε  έΧ oυν  αν άγκη
18 My life is pretty full 1.69 1.00 3.22 0.91 0.000
H ζω ή µoυ  ε ίναι  γεµ άτη
19 I feel that others would be better off if I were dead 1.67 0.93 1.07 0.42 0.000
Aισθ άνοµαι  óτι  θα  ήταν  καλ ύτερα  για  τ oυζ  άλλ oυζα  νεγ ώ π έθαινα
20 I still enjoy the things I used to do 1.87 1.13 3.20 0.95 0.000
Aκ óµα  απ oλαµβ άνω  τα  πρ άγµατα  π oυ  συν ήθιζα  να  κ άνω .
ZDRS score 54.26 8.97 32.98 7.88 0.000
Fact 1 score Anxious and depressed affect 0.71 1.34 -0.24 0.72 0.000
Fact 2 score Thought content -0.20 0.97 0.07 1.00 0.135
Fact 3 score Gastrenterological problems -0.54 1.39 0.18 0.76 0.000
Fact 4 score Irritability -0.34 1.17 0.11 0.92 0.012
Fact 5 score Social Functioning 0.63 1.28 -0.21 0.79 0.000BMC Psychiatry 2001, 1 http://www.biomedcentral.com/1471-244X/1/6
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is not conclusive. For the purpose of exploring the psycho-
metric properties of the ZDRS, two studies were done us-
ing subjects from two markedly different socio-cultural
settings: 213 male and female drug addicts in New York
City and 206 male and female undergraduates in Nigeria.
Findings included high coefficient alphas and large aver-
age item-correlations (total minus item) in both studies.
It was concluded that the ZDRS rates well in terms of in-
ternal consistency reliability and construct validity [29].
Using both the English version and an Igbo translation of
ZDRS in 132 first-time attenders to a hospital-based gen-
Table 4: Discriminant Function Analysis Results.
A
Classification Functions Classification Matrix
SDS item No normal depressed D-C Rows: Observed classifications
comparison
subjects
Constant -47.84 -63.36 -15.52 Columns: Predicted classifications
Item No 1 4.50 7.15 2.65 % normal depressed
Correct comparison
subjects
Item No 2 2.32 1.87 -0.45 Comp subjects 100.00 120 0
Item No 3 4.05 6.08 2.03 depressed 90.00 4 36
Item No 4 3.10 4.24 1.14 Total 97.50 124 36
Item No 6 3.00 2.03 -0.97
Item No 7 3.19 4.74 1.56
Item No 8 3.32 4.14 0.82
Item No 9 1.35 2.53 1.18
Item No 10 2.04 3.17 1.13
Item No 11 4.46 5.48 1.02
Item No 12 3.12 0.75 -2.37
Item No 15 4.59 3.12 -1.46
Item No 16 2.06 2.98 0.91
Item No 17 0.02 0.99 0.97
B
Classification Functions Classification Matrix
Factor No normal depressed D-C Rows: Observed classifications
comparison
subjects
Constant -0.42 -2.63 -2.21 Columns: Predicted classifications
Factor 1 -0.43 1.30 1.72 % normal depressed
Correct comparison
subjects
Factor 2 0.12 -0.37 -0.49 Comp subj 95.00 114 6
Factor 3 0.32 -0.98 -1.30 depressed 72.50 11 29
Factor 4 0.21 -0.62 -0.83 Total 89.38 125 35
Factor 5 -0.38 1.15 1.53
Analysis with individual ZDRS items entering the procedure. When the equation: 2.65*(itl) - 0.45*(it2) + 2.03*(it3) + 1.14*(it4) - 0.97*(it6) + 
1.56*(it7) + 0.82*(it8) + 1.18*(it9) + 1.13*(it10) + 1.02*(itll) - 2.37*(it12) - 1.46*(it15) + 0.91*(itl6) + 0.97** itl7) > 15.52 is true, then the subject is 
a depressed patient. This method correctly classified all normal comparison subjects and 90% of patients. B: Analysis with factor scores entering the 
procedure. When the equation: 1.72*(f1) - 0.49*(f2) - 1.3*(f3) - 0.83*(f4) + 1.53*(f5) > 2.21 is true, then the subject is a depressed patient. This 
method correctly classified 95% of normal comparison subjects and 72.5% of patientsBMC Psychiatry 2001, 1 http://www.biomedcentral.com/1471-244X/1/6
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eral outpatient clinic a prevalence rate of 25% for depres-
sive symptoms was obtained. Fourteen percent scored
within the range for "mild depression", while 11% ob-
tained scores within the range for "moderate depression"
[30].
Review studies on various self-administered instruments
suggest that there is no significant difference between var-
ious self-administered depressive scales in terms of per-
formance. Overall sensitivity is around 84% and
specificity around 72% [31]. These instruments are of par-
ticular value in primary care settings because it is clear that
primary care providers fail to diagnose and treat as many
as 35% to 50% of patients with depressive disorders
[32,33]. Depression is one of the most common psychiat-
ric diagnoses in primary care populations [34]; major de-
pressive disorders can be diagnosed in 6% to 9% of such
patients. Obstacles to the appropriate recognition of de-
pression include inadequate provider knowledge of diag-
nostic criteria; competing comorbid conditions and
priorities among primary care patients; time limitations in
busy office settings; concern about the implications of la-
beling; poor reimbursement mechanisms; and uncertain-
ty about the value, accuracy, and efficiency of screening
mechanisms for identifying patients with depression. Giv-
en that 50% to 60% of persons seeking help for depres-
sion are treated exclusively in the primary care setting,
accurate detection in this setting is important [35] and self
– administered instruments may help to ameliolate some
of them. Many studies have assessed the effect of feedback
of scale scores on physician practice patterns [36–45] and
have shown improved recognition of depression with
such feedback.
On the other hand, it should be noted that the diagnosis
of depression is itself based on symptoms. A patient can-
not truly be asymptomatic and have major depressive dis-
order. Thus, these screening questionnaires are actually
being evaluated for their ability to detect unrecognized,
rather than strictly asymptomatic, depressive symptoms
and disease.
The Canadian Task Force on the Periodic Health Examina-
tion found fair evidence to exclude the use of depression
detection tests from the periodic health examination of
asymptomatic people [46]. The American Academy of
Family Physicians advises physicians to remain alert for
depressive symptoms in adolescents and adults [47]; this
policy is under review. The American Medical Association
recommends that all adolescents be asked annually about
behaviors or emotions that indicate recurrent or severe de-
pression [48].
Conclusion
The Greek translation of the ZDRS scale is both reliable
and valid and is suitable for clinical and research use with
satisfactory properties. However one should always have
in mind the limitations inherent in the use of self-report-
ing scales.
The very low internal consistency of the scale, reported by
the current study suggests that the ZDRS is not a unidi-
mensional scale. It is also evident that its development
was not based on the contemporary definition of depres-
sion but rather on that of the sixties. Thus, although sen-
sitivity and specificity were proved to be high, the
interpretation of its results should be made with caution.
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